drug · small molecule
delamanid
Phase 3updated 3mo agoby Otsuka Pharmaceutical Co Ltd🔗 ChEMBL
Phase 3community read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 3 approved and 2 investigational indications.
all catalysts(0)
nothing on the calendar yet
Trials studying delamanid
- phase2Safety and Efficacy Evaluation of 4-month Regimen of OPC-167832, Delamanid and Bedaquiline in Participants With Drug-Susceptible Pulmonary TB
- phase2Efficacy and Tolerability of Bedaquiline, Delamanid, Levofloxacin, Linezolid, and Clofazimine to Treat MDR-TB
- phase2A Phase 2b Clinical Study of JDB0131 Benzenesulfonate Tablets
- phase2Early Bactericidal Activity, Safety & Tolerability of Oral GSK3036656 in a Dual Combination With Novel and Established Antitubercular Agents, or Standard of Care in Adults With Rifampicin Susceptible Pulmonary Tuberculosis
- phase2Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB
- phase2PanACEA DElpazolid Dose-finding and COmbination DEvelopment (DECODE)
- phase3Protecting Households On Exposure to Newly Diagnosed Index Multidrug-Resistant Tuberculosis Patients
- phase2Evaluating the Pharmacokinetics, Safety, and Tolerability of Delamanid in Combination With Optimized Multidrug Background Regimen (OBR) for Multidrug-Resistant Tuberculosis (MDR-TB) in HIV-Infected and HIV-Uninfected Children With MDR-TB
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 5m ago
Found something off?
comments(0)
5-min edit window · permanent after that